In clinical trials, three independent groups reported vision improvements upon the viral-mediated delivery of the Rpe65 gene in patients with Rpe65-associated Leber’s congenital amaurosis (LCA) [89,90,91]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.